Abatacept and anti-TNF monoclonal antibodies: efficacy and safety comparisons

被引：0
|
作者：
Schiff, M. [1 ]
Dougados, M. [2 ]
Fleischmann, R. [3 ]
Fay, J. [4 ]
Maldonado, M. [4 ]
机构：
[1] Univ Colorado, Sch Med, Div Rheumatol, Denver, CO USA
[2] Hop Cochin, Dept Rheumatol, F-75674 Paris, France
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [1] ABATACEPT AND ANTI-TNF MONOCLONAL ANTIBODIES: EFFICACY AND SAFETY COMPARISONS
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 461 - 462
  • [2] Abatacept and Anti-Tumor Necrosis Factor Monoclonal Antibodies: Efficacy and Safety Comparisons
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1004 - S1004
  • [3] Abatacept and Anti-Tumor Necrosis Factor Monoclonal Antibodies: Efficacy and Safety Comparisons
    Schiff, Michael
    Dougados, Maxime
    Fleischmann, Roy
    Fay, Jon
    Maldonado, Michael
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1474 - 1474
  • [4] The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
    Allez, M.
    Vermeire, S.
    Mozziconacci, N.
    Michetti, P.
    Laharie, D.
    Louis, E.
    Bigard, M. -A.
    Hebuterne, X.
    Treton, X.
    Kohn, A.
    Marteau, P.
    Cortot, A.
    Nichita, C.
    van Assche, G.
    Rutgeerts, P.
    Lemann, M.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 31 (01) : 92 - 101
  • [5] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Hirabara, Shinya
    Takahashi, Nobunori
    Fukaya, Naoki
    Miyake, Hiroyuki
    Yabe, Yuichiro
    Kaneko, Atsushi
    Ito, Takayasu
    Oguchi, Takeshi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Sugiura, Fumiaki
    Hayashi, Masatoshi
    Funahashi, Koji
    Hanabayashi, Masahiro
    Asai, Shuji
    Ishiguro, Naoki
    Kojima, Toshihisa
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1247 - 1254
  • [6] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Shinya Hirabara
    Nobunori Takahashi
    Naoki Fukaya
    Hiroyuki Miyake
    Yuichiro Yabe
    Atsushi Kaneko
    Takayasu Ito
    Takeshi Oguchi
    Daihei Kida
    Yuji Hirano
    Takayoshi Fujibayashi
    Fumiaki Sugiura
    Masatoshi Hayashi
    Koji Funahashi
    Masahiro Hanabayashi
    Shuji Asai
    Naoki Ishiguro
    Toshihisa Kojima
    Clinical Rheumatology, 2014, 33 : 1247 - 1254
  • [7] EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO ANTI-TNF THERAPY BY NUMBER OF PRIOR ANTI-TNF THERAPIES USED
    Schiff, M.
    Le Bars, M.
    Gaillez, C.
    Wu, G.
    Poncet, C.
    Genovese, M. C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S29 - S30
  • [8] Placental transfer of monoclonal antibodies: The example of anti-TNF alpha drugs
    Beghin, D.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2021, 49 (09): : 724 - 726
  • [9] Monoclonal anti-TNF antibodies may increase risk of herpes zoster
    Reactions Weekly, 2009, 1241 (1) : 5 - 5
  • [10] Practical use of anti-TNF monoclonal antibodies in inflammatory bowel diseases
    Allez, M.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 467 - 477
12345